Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
18 | 26857540 | intron variant | A/C | snv |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||||
|
0.882 | 0.240 | 18 | 26862297 | missense variant | C/G | snv |
|
Cardiovascular Diseases | 0.700 | 0 | |||||||||||
|
0.882 | 0.240 | 18 | 26862297 | missense variant | C/G | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.882 | 0.240 | 18 | 26862297 | missense variant | C/G | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases | 0.700 | 0 | |||||||||||
|
0.882 | 0.240 | 18 | 26862297 | missense variant | C/G | snv |
|
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.882 | 0.240 | 18 | 26862297 | missense variant | C/G | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.240 | 18 | 26862297 | missense variant | C/G | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.851 | 0.200 | 18 | 26866562 | intron variant | G/A | snv | 0.31 |
|
Pathological Conditions, Signs and Symptoms | 0.020 | 1.000 | 2 | 2010 | 2014 | |||||||
|
1.000 | 0.120 | 18 | 26862573 | stop gained | C/A;G | snv | 3.2E-05; 2.9E-04 |
|
Eye Diseases; Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.200 | 18 | 26866562 | intron variant | G/A | snv | 0.31 |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.851 | 0.200 | 18 | 26866562 | intron variant | G/A | snv | 0.31 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.851 | 0.200 | 18 | 26866562 | intron variant | G/A | snv | 0.31 |
|
Eye Diseases; Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.851 | 0.200 | 18 | 26866562 | intron variant | G/A | snv | 0.31 |
|
Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 18 | 26864410 | intron variant | G/A;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 18 | 26864410 | intron variant | G/A;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 18 | 26864410 | intron variant | G/A;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
0.925 | 0.080 | 18 | 26855854 | 3 prime UTR variant | C/T | snv | 0.30 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 18 | 26855854 | 3 prime UTR variant | C/T | snv | 0.30 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 18 | 26855854 | 3 prime UTR variant | C/T | snv | 0.30 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 18 | 26865469 | intron variant | T/C | snv | 0.19 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 18 | 26865469 | intron variant | T/C | snv | 0.19 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 18 | 26865469 | intron variant | T/C | snv | 0.19 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 18 | 26856350 | missense variant | A/G | snv |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.040 | 18 | 26866839 | intron variant | C/A;T | snv | 8.1E-02 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2017 | 2017 |